(Q24187979)

2

0 references

Khaled Ezzedine

object named as

Khaled Ezzedine

8

0 references

author name string

Maxine E Whitton

1

0 references

Jonathan Batchelor

3

0 references

Urbà González

5

0 references

Zainab Jiyad

6

0 references

Viktoria Eleftheriadou

Cochrane Database of Systematic Reviews

7

0 references

publication date

24 February 2015

0 references

published in

0 references

cites work

A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasone and calcipotriol in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Comparison between autologous noncultured epidermal cell suspension and suction blister epidermal grafting in stable vitiligo: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Response of vitiligo to narrowband ultraviolet B and oral antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

BB-UVA vs. NB-UVB in the treatment of vitiligo: a randomized controlled clinical study (single blinded).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

A comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Segmental vitiligo: a randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Tacalcitol and narrow-band phototherapy in patients with vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Combination treatment of non-segmental vitiligo with a 308-nm xenon chloride excimer laser and topical high-concentration tacalcitol: a prospective, single-blinded, paired, comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad / narrow band UVB phototherapy in progressive vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: a randomized intra-individual open comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Clinical observation on the effect of Zengse Pill in treating patients with vitiligo of qi-stagnancy and blood-stasis syndrome type

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Comparison of the 308-nm excimer laser with the 308-nm excimer lamp in the treatment of vitiligo--a randomized bilateral comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

L-phenylalanine and UVA irradiation in the treatment of vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Comparison between autologous noncultured extracted hair follicle outer root sheath cell suspension and autologous noncultured epidermal cell suspension in the treatment of stable vitiligo: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Efficacy of autologous transplantation of noncultured epidermal suspension in two different dilutions in the treatment of vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Original article title: "Comparison of therapeutic efficacy of topical corticosteroid and oral zinc sulfate-topical corticosteroid combination in the treatment of vitiligo patients: a clinical trial".

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

PUVA and PUVB in vitiligo--are they equally effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Narrow band Ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Comparison of two diluents of 1% methoxsalen in the treatment of vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Role of the ACTH test and estimation of a safe dose for high potency steroids in vitiligo: A prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Feasibility, double-blind, randomised, placebo-controlled, multi-centre trial of hand-held NB-UVB phototherapy for the treatment of vitiligo at home (HI-Light trial: Home Intervention of Light therapy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Comparing Nigella sativa Oil and Fish Oil in Treatment of Vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Evaluation of the Efficacy of Topical Tetracycline in Enhancing the Effect of Narrow Band UVB against Vitiligo: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

The effect of pseudocatalase/superoxide dismutase in the treatment of vitiligo: A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

A comparative study of efficacy of cultured versus non cultured melanocyte transfer in the management of stable vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Serum antibodies in vitiligo patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

The effectiveness of therapeutic interventions on quality of life for vitiligo patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Pre- vs. post-pubertal onset of vitiligo: multivariate analysis indicates atopic diathesis association in pre-pubertal onset vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation pattern.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Current state of vitiligo therapy--evidence-based analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Micropigmentation in vitiligo of lateral lower lip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Non-psoralen treatment of vitiligo. Part II. Less commonly used and experimental therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Guidelines for designing and reporting clinical trials in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Ultraviolet-based therapy for vitiligo: what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

NALP1 in vitiligo-associated multiple autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

A review of the worldwide prevalence of vitiligo in children/adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Interventions for infantile haemangiomas (strawberry birthmarks) of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Surgical interventions for vitiligo: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Effect of vitiligo on self-reported health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

A review of monochromatic excimer light in vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Quality of life in patients with vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Autoimmunity as an aetiological factor in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Innate immune mechanisms in vitiligo: danger from within

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Quality of life impairment in children and adolescents with vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Modern vitiligo genetics sheds new light on an ancient disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

A systematic review of natural health product treatment for vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Vitiligo is more than skin deep: a survey of members of the Vitiligo Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Vitiligo as an inflammatory skin disorder: a therapeutic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Measurement properties of outcome measures for vitiligo. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Interventions for vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Left-right comparison study of the combination of fluticasone propionate and UV-A vs. either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Vitiligo treated with topical clobetasol propionate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

1 reference

7 January 2021

On the etiology of vitiligo and gray hair

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Psychological reaction to chronic skin disorders: a study of patients with vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

The effect of vitiligo on sexual relationships

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Efficacy of narrowband ultraviolet B versus excimer radiation in repigmenting vitiligo after minigrafting on the distal arms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: A pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

1 reference

7 January 2021

The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Comparison of two surgical approaches for treating vitiligo: a preliminary study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Comparison of minipunch grafting versus split-skin grafting in chronic stable vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Efficacy and safety of autologous cultured melanocytes delivered on poly (DL-lactic acid) film: a prospective, open-label, randomized, multicenter study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

The treatment of vitiligo with psoralens and triamcinolone by mouth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Treatment of vitiligo with 0-1 per cent betamethasone 17-valerate in isopropyl alcohol--a double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Impact of childhood vitiligo on adult life

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Punchgraft testing in vitiligo; effects of UVA, NB-UVB and 632.8 nm Helium-Neon laser on the outcome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Autologous Noncultured Melanocyte Transplantation for Stable Vitiligo: Can Suspending Autologous Melanocytes in the Patientsʼ Own Serum Improve Repigmentation and Patient Satisfaction?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Characterization of vitiligo antigens

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

The genetics of generalized vitiligo and associated autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Ultraviolet A in vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Combination of PUVAsol and Topical Calcipotriol in Vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Can topical phenytoin augment the therapeutic efficacy of PUVA against vitiligo? A double-blind, randomized, bilateral-comparison, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

WITHDRAWN: Comparision between 308-nm excimer laser and 308-nm excimer lamp in the treatment of vitiligo - a randomized self control study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

The psychosocial impact of vitiligo in Indian patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021

Histopathological characteristics of post kala-azar dermal leishmaniasis: a series of 88 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB5

7 January 2021